Triad Rx, Inc.

FDA inspection history in Daphne, Alabama, 2017 to 2023

2
Close-outs
2
Form 483s

Every document, by year

  • Close-out
  • Form 483

2017: one Form 483; 2019: one close-out letter; 2022: one Form 483; 2023: one close-out letter.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2017–19One Form 483 and one close-out letter, at Daphne, Alabama.
  2. 2017The longest 483 on file: 9 observations over 3 pages at Daphne, Alabama.
  3. 2022–23One Form 483 and one close-out letter, at Daphne, Alabama.

Cited most

Across all Triad Rx observations on file

  • 21 CFR 211.113
    Control of microbiological contamination
    8
  • 21 CFR 211.42
    Design and construction features
    1
  • FDCA 501(a)(2)(A)
    Insanitary conditions
    1

The complete Triad Rx file.

All 4 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$396

The price of the documents, added to your cart together

Sites

Documents

4 on file, newest first
DateDocumentPrice
2023-05-03Close-out Close-out letter$99
2022-12-08483 Form 483$99
2019-02-05Close-out Close-out letter$99
2017-07-21483 Form 483$99

Investigators on these documents

Brandon C. Heitmeier (1)Veronica Fuentes (1)

FEI number 3013497126 · most recent document May 3, 2023

About Triad Rx, Inc.

How many FDA Form 483s has Triad Rx, Inc. received?

FDA Intel has 2 Form 483s on file for Triad Rx, Inc.; the most recent is dated Dec 8, 2022.

When was Triad Rx, Inc. last inspected by FDA?

The most recent FDA inspection document on file for Triad Rx, Inc. is a Form 483 dated Dec 8, 2022, for the site in Daphne, Alabama.

What did FDA cite at Triad Rx, Inc.?

The regulations cited most in the observations on file for Triad Rx, Inc. are 21 CFR 211.113 (Control of microbiological contamination), 8 times; 21 CFR 211.42 (Design and construction features), 1 time; FDCA 501(a)(2)(A) (Insanitary conditions), 1 time.